Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026)

Canton Strategic Holdings (CNTN) reported Cash from Investing Activities of -$54.8 million for Q1 2026.

Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026) Analysis & Trends

Canton Strategic Holdings has reported Cash from Investing Activities for 1 years, with the latest figure at -$54.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - -54.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -54.82 Mn
Mar 31, 2026 -54.82 Mn